PD-ECGF Rekombinanter Antikörper
PD-ECGF Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
251581B2
Kat-Nr. : 86618-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86618-3-PBS bindet in WB, Indirect ELISA PD-ECGF und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | PD-ECGF fusion protein Ag3052 |
| Vollständiger Name | thymidine phosphorylase |
| Berechnetes Molekulargewicht | 482 aa, 50 kDa |
| Beobachtetes Molekulargewicht | 50 kDa |
| GenBank-Zugangsnummer | BC018160 |
| Gene symbol | Thymidine phosphorylase |
| Gene ID (NCBI) | 1890 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Platelet derived endothelial cell growth factor (PD-ECGF), also known as thymidine phosphorylase (TP), induces migration and angiogenesis in endothelial and tumor cells, and was upregulated in various malignancies compared to that in normal tissues. Interestingly, PD-ECGF has dual effect on tumor development and chemotherapy. It could stimulate cancer cell migration and proliferation. On the other hand, some chemotherapeutic agents (5-fluorouracil, capecitabine, etc.) were converted to their active forms through TP enzymes.





